Oxford Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Oxford Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-60,812	Closed	-$353K	–	2265
2018 Q3	$353K	Buy	60,812 +5,441	+10%	+$27.2K	0.01%	1449
2018 Q2	$233K	Buy	55,371 +43,171	+354%	+$218K	﹤0.01%	1558
2018 Q1	$54K	Sell	12,200 -50,787	-81%	-$227K	﹤0.01%	1557
2017 Q4	$338K	Buy	+62,987	New	+$385K	0.01%	1307
2017 Q1	–	Sell	-247,908	Closed	-$1.78M	–	1530
2016 Q4	$1.78M	Sell	247,908 -48,418	-16%	-$391K	0.06%	356
2016 Q3	$2.77M	Buy	296,326 +285,984	+2,765%	+$2.37M	0.09%	325
2016 Q2	$65K	Buy	+10,342	New	+$66.5K	﹤0.01%	748

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Oxford Asset Management's PETX Position: Q4 2018 in Review

Oxford Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2018, closing a stake of 60,812 shares — an estimated $353K sold.

Oxford Asset Management first reported a position in PETX in Q2 2016 and held it in 7 quarters. The position peaked at $2.77M in Q3 2016. 115 funds tracked by Wall St. Rank hold PETX as of Q4 2018.

Oxford Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
Oxford Asset Management sold 60,812 Aratana Therapeutics, Inc. shares in Q4 2018, an estimated $353K.
Oxford Asset Management first reported a position in Aratana Therapeutics, Inc. in Q2 2016 and held it in 7 quarters.
Oxford Asset Management's Aratana Therapeutics, Inc. position peaked at $2.77M in Q3 2016.
115 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2018.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.